July 7, 2011
Cepheid Schedules 2011 Second Quarter Financial Results Announcement and Webcast
SUNNYVALE, Calif., July 7, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2011 second quarter ended June 30, 2011, on Thursday, July 21, 2011, after the close of the market.
The company will host a management presentation at 2 p.m. Pacific Time on Thursday, July 21, 2011, to discuss the results. To access the live webcast, please visit Cepheid's website at www.cepheid.com/investors at least 15 minutes before the scheduled start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the call and will remain available for at least 90 days.Interested participants and investors may also listen to the live teleconference call by dialing (866) 804-6926 or (857) 350-1672, and entering participant code 75697734. A replay will be available for seven days beginning at 4 p.m. Pacific Time. Access numbers for this replay are (888) 286-8010 or (617) 801-6888, with passcode 67835349.
Based in Sunnyvale, Calif., Cepheid is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.
CONTACTS: For Media Inquiries: For Investor Inquiries: -------------------- ----------------------- Jared Tipton Jacquie Ross Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 [email protected] [email protected]